Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015
Mineralocorticoid receptor antagonists (MCRA) are part of standard medical therapy for heart failure (HF). The clinical efficacy of MCRA in patients with systolic HF has been proven by randomized clinical trials. The efficacy of this drug group in patients with chronic HF with preserved left ventric...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
"Consilium Medicum" Publishing house
2015-09-01
|
| Series: | Терапевтический архив |
| Subjects: | |
| Online Access: | https://ter-arkhiv.ru/0040-3660/article/view/31823 |
| id |
doaj-26cb7b3f95ef4361b51e73d58b72a6c1 |
|---|---|
| record_format |
Article |
| spelling |
doaj-26cb7b3f95ef4361b51e73d58b72a6c12020-11-25T03:23:07Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422015-09-01879778328839Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015Yu F OsmolovskayaI V ZhirovS N TereshchenkoMineralocorticoid receptor antagonists (MCRA) are part of standard medical therapy for heart failure (HF). The clinical efficacy of MCRA in patients with systolic HF has been proven by randomized clinical trials. The efficacy of this drug group in patients with chronic HF with preserved left ventricular systolic function and the advent and practical introductions of safer new-generation MCRA remain to be answered.https://ter-arkhiv.ru/0040-3660/article/view/31823aldosteronemineralocorticoid receptor antagonistschronic heart failure |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
Yu F Osmolovskaya I V Zhirov S N Tereshchenko |
| spellingShingle |
Yu F Osmolovskaya I V Zhirov S N Tereshchenko Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015 Терапевтический архив aldosterone mineralocorticoid receptor antagonists chronic heart failure |
| author_facet |
Yu F Osmolovskaya I V Zhirov S N Tereshchenko |
| author_sort |
Yu F Osmolovskaya |
| title |
Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015 |
| title_short |
Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015 |
| title_full |
Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015 |
| title_fullStr |
Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015 |
| title_full_unstemmed |
Mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. Positions in 2015 |
| title_sort |
mineralocorticoid receptor antagonists in the treatment of patients with chronic heart failure. positions in 2015 |
| publisher |
"Consilium Medicum" Publishing house |
| series |
Терапевтический архив |
| issn |
0040-3660 2309-5342 |
| publishDate |
2015-09-01 |
| description |
Mineralocorticoid receptor antagonists (MCRA) are part of standard medical therapy for heart failure (HF). The clinical efficacy of MCRA in patients with systolic HF has been proven by randomized clinical trials. The efficacy of this drug group in patients with chronic HF with preserved left ventricular systolic function and the advent and practical introductions of safer new-generation MCRA remain to be answered. |
| topic |
aldosterone mineralocorticoid receptor antagonists chronic heart failure |
| url |
https://ter-arkhiv.ru/0040-3660/article/view/31823 |
| work_keys_str_mv |
AT yufosmolovskaya mineralocorticoidreceptorantagonistsinthetreatmentofpatientswithchronicheartfailurepositionsin2015 AT ivzhirov mineralocorticoidreceptorantagonistsinthetreatmentofpatientswithchronicheartfailurepositionsin2015 AT sntereshchenko mineralocorticoidreceptorantagonistsinthetreatmentofpatientswithchronicheartfailurepositionsin2015 |
| _version_ |
1724607626056040448 |